-
THE ECONOMIC AND HUMANISTIC BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN UAE
Aug 11, 2026, 17:15 PM -
INTRODUCING IN THE NATIONAL IMMUNIZATION PROGRAM THE 20-VALENT PNEUMOCOCCAL VACCINE IN OLDER ADULTS IN ECUADOR: A COST-UTILITY ANALYSIS
Aug 11, 2026, 17:15 PM -
FROM STANDALONE AI TO NATIONAL WORKFLOW: INDEPENDENT EVALUATION OF AN ELECTIVE-CARE RISK-STRATIFICATION TOOL'S CLINICAL AND BUDGET IMPACT, WITH FEDERATED DATA PLATFORM INTEGRATION
Aug 11, 2026, 17:15 PM -
HOSPITAL RESOURCE OPTIMIZATION WITH SUBCUTANEOUS IMMUNOTHERAPY IN LUNG CANCER: A REAL-WORLD ORGANIZATIONAL AND ECONOMIC ASSESSMENT
Aug 11, 2026, 17:15 PM -
A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC AND HUMANISTIC BURDEN OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)
Aug 11, 2026, 17:15 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CYSTIC FIBROSIS IN TURKIYE: A SCOPING REVIEW
Aug 11, 2026, 17:15 PM -
FROM EVIDENCE GAPS TO LAUNCH READINESS: WHICH EVIDENCE UNCERTAINTIES RESTRICT PATIENT ACCESS?
Aug 11, 2026, 17:15 PM -
COMPARISON OF GPT-5 MODELS FOR ARTIFICIAL INTELLIGENCE (AI)-ASSISTED DATA EXTRACTION FROM RANDOMIZED CLINICAL TRIALS (RCTS) IN SYSTEMATIC LITERATURE REVIEWS (SLRS): ACCURACY, REPRODUCIBILITY, AND TIME-EFFICIENCY
Aug 11, 2026, 17:15 PM -
QUALITY-OF-LIFE EVIDENCE IN FRENCH HEALTH TECHNOLOGY ASSESSMENT: A LANDSCAPE OF CEESP ECONOMIC OPINIONS, 2021-2026
Aug 11, 2026, 17:15 PM -
COSTS BY DISABILITY SEVERITY AND ASSOCIATION WITH EDSS IN MULTIPLE SCLEROSIS ACROSS EU5: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
A RANDOMISED TRIAL IS NOT ENOUGH: PICO FEASIBILITY FOR FIRST-LINE DURVALUMAB IN HEPATOCELLULAR CARCINOMA
Aug 11, 2026, 17:15 PM -
OUTCOMES-BASED AGREEMENT ARCHITECTURE FOR CELL AND GENE THERAPIES: TRANSLATING EU5 STAGED PAYMENT MODELS FOR CMS IMPLEMENTATION
Aug 11, 2026, 17:15 PM -
THE BIOSECURE EFFECT: EU MARKET ACCESS IMPLICATIONS FOR CHINA-ORIGINATED PD-(L)1 INHIBITORS
Aug 11, 2026, 17:15 PM -
BIOMARKERS ASSOCIATED WITH RISK OF SYSTEMIC COMPLICATIONS IN SJOGREN'S DISEASE: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
THE DUTCH STEPWISE WILLINGNESS-TO-PAY THRESHOLDS: INCREASING CHALLENGES FOR ACCESS TO NEXT-GENERATION DRUG INNOVATIONS
Aug 11, 2026, 17:15 PM -
CONVERSION-TO-OPEN SURGERY AVOIDED BY ROBOTIC-ASSISTED SURGERY IN SWEDISH COLORECTAL CANCER: A 10-YEAR NATIONAL-REGISTRY BUDGET-IMPACT ANALYSIS, 2015-2024
Aug 11, 2026, 17:15 PM -
CLAIMS-BASED LIPID-LOWERING THERAPY COVERAGE COMPARED TO CONVENTIONAL DRUG-SPECIFIC MEDICATION ADHERENCE AND PERSISTENCE METRICS
Aug 11, 2026, 17:15 PM -
SOCIO-ECONOMIC BURDEN OF ADHD: GLOBAL INSIGHTS AND PRELIMINARY FINDINGS FROM HONG KONG
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF ADJUVANTED RSVPREF3 OA VACCINE IN ADULTS AGED =75 YEARS AND THE COMORBID POPULATION AGED 60-74 YEARS IN SWITZERLAND
Aug 11, 2026, 17:15 PM -
HEALTH IMPACT AND COST-EFFECTIVENESS OF DIGITAL MESSAGING NUDGES ON INFLUENZA VACCINE UPTAKE AMONG CHINESE OLDER ADULTS: A REAL-WORLD TRIAL
Aug 11, 2026, 17:15 PM
